Kunchok et al. (2019) reported that patients with GFAP astrocytopathy more frequently experience myelopathic symptoms including sensory and mild motor symptoms, rather than severe paresis/plegia from myelitis, in contrast to patients with AQP4 NMOSD [19]. This evidence concerns the gene GFAP and myelitis.